Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126421251 | 12642125 | 1 | I | 20160721 | 20160729 | 20160810 | 20160810 | EXP | GB-MHRA-TPP26845698C1321476YC1469103353838 | GB-TEVA-682704ACC | TEVA | 34.00 | YR | F | Y | 135.00000 | KG | 20160810 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126421251 | 12642125 | 1 | PS | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | U | U | 18679 | ||||||||||
| 126421251 | 12642125 | 2 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | 2 DOSAGE FORMS DAILY; | 48 | DF | 0 | 1 | DF | Q12H | ||||||
| 126421251 | 12642125 | 3 | C | COCODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | TAKE 1 OR 2 UP TO 4 TIMES/DAY | 0 | |||||||||||
| 126421251 | 12642125 | 4 | C | ERYTHROMYCIN. | ERYTHROMYCIN | 1 | 4000 MILLIGRAM DAILY; | 4000 | MG | 0 | 1000 | MG | TABLET | QID | |||||
| 126421251 | 12642125 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | 3 DOSAGE FORMS DAILY; | 315 | DF | 0 | 1 | DF | TID | ||||||
| 126421251 | 12642125 | 6 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 1 DOSAGE FORMS DAILY; | 105 | DF | 0 | 1 | DF | QD | ||||||
| 126421251 | 12642125 | 7 | C | LAXIDO | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | 1 DOSAGE FORMS DAILY; | 6 | DF | 0 | 1 | DF | QD | ||||||
| 126421251 | 12642125 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | TAKE 1 OR 2 4 TIMES/DAY | 0 | QID | ||||||||||
| 126421251 | 12642125 | 9 | C | RANITIDINE. | RANITIDINE | 1 | 2 DOSAGE FORMS DAILY; | 210 | DF | 0 | 1 | DF | BID | ||||||
| 126421251 | 12642125 | 10 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 1 DOSAGE FORMS DAILY; | 105 | DF | 0 | 1 | DF | TABLET | QD | |||||
| 126421251 | 12642125 | 11 | C | VARENICLINE | VARENICLINE | 1 | 2 DOSAGE FORMS DAILY; | 32 | DF | 0 | 1 | DF | BID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126421251 | 12642125 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126421251 | 12642125 | Pharyngeal oedema | |
| 126421251 | 12642125 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126421251 | 12642125 | 1 | 20160720 | 0 | ||
| 126421251 | 12642125 | 2 | 20160627 | 20160704 | 0 | |
| 126421251 | 12642125 | 3 | 20160715 | 0 | ||
| 126421251 | 12642125 | 4 | 20160720 | 0 | ||
| 126421251 | 12642125 | 5 | 20160407 | 0 | ||
| 126421251 | 12642125 | 6 | 20160407 | 0 | ||
| 126421251 | 12642125 | 7 | 20160715 | 0 | ||
| 126421251 | 12642125 | 8 | 20160407 | 0 | ||
| 126421251 | 12642125 | 9 | 20160407 | 0 | ||
| 126421251 | 12642125 | 10 | 20160407 | 0 | ||
| 126421251 | 12642125 | 11 | 20160705 | 20160719 | 0 |